Netherlands· NL-aa3362978050
Zepatier 50mg/100mg, filmomhulde tablet
A elbasvir and grazoprevir product containing elbasvir + grazoprevir 1-water, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Elbasvir and grazoprevir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AP54 (elbasvir and grazoprevir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Elbasvir and grazoprevir · ATC J05AP54
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ELBASVIR + GRAZOPREVIR 1-WATER
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Netherlands (NL)
- ATC code
- J05AP54
- ATC class
- Elbasvir and grazoprevir
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/16/1119
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elbasvir and grazoprevir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomZepatier 50mg/100mg tabletsOriginalis B.V.
- SpainZEPATIER 50MG/100MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandZEPATIERMerck Sharp & Dohme B.V.
- FranceZEPATIER 50 mg/100 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandZEPATIER 50 mg/100 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandZepatierMerck Sharp & Dohme B.V.*
- PolandZepatierMerck Sharp & Dohme B.V.
- SwedenZEPATIER 50 mg/100 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zepatier
- Liechtenstein · Zepatier
- Norway · Zepatier
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b2a67ed-85c1-4b2c-a2c1-c3e0ac8b26bf GET /v1/drugs/7b2a67ed-85c1-4b2c-a2c1-c3e0ac8b26bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zepatier-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Elbasvir and grazoprevir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp117665",
"excipients": [
"CARNAUBAWAS (E 903)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"COPOVIDON (E 1208)",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"NATRIUMCHLORIDE",
"NATRIUMLAURILSULFAAT",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)",
"TOCOFERSOLAN"
],
"substances": [
"ELBASVIR",
"GRAZOPREVIR 1-WATER"
],
"leaflet_url": null,
"authorised_at": "2016/07/22",
"procedure_number": "EMEA/H/C/004126",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/16/1119",
"additional_monitoring": "N"
}See everything about elbasvir and grazoprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.